Clinical Trial Update: Efficacy and Safety of Asenapine Treatment for Pediatric Bipolar Disorder (P06107 Has an Extension [P05898; NCT01349907])(P06107) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated the efficacy and safety of asenapine for pediatric bipolar disorder; the study completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Asenapine (asenapine)

Snippet

Sponsor: Organon and Co | Conditions: Bipolar Disorder, Pediatric | Phase 3 | Status: COMPLETED | Results posted: 2014-09-04